Ribosomal Protein S3 Gene Silencing Protects Against Experimental Allergic Asthma

Conclusions and ImplicationsWe reported here that RPS3 gene silencing ameliorated experimental asthma probably via interruption of the NF‐κB activity, postulating that RPS3 is a novel therapeutic target for allergic airway inflammation.

Source: British Journal of Pharmacology - December 31, 2016 Category: Drugs & Pharmacology Authors: Jinrui Dong, Wupeng Liao, Hong Yong Peh, Tze Khee Chan, W. S. Daniel Tan, Li Li, Amy Yong, W. S. Fred Wong Tags: RESEARCH PAPER Source Type: research